Comparison of Two Different Approaches in the Fascia Iliaca Compartment Block in Femoral Fracture Surgery
1 other identifier
interventional
68
1 country
1
Brief Summary
Fascia Iliaca Compartment Block (FICB) is a popular regional anaesthetic technique for surgical procedures involving the hip joint and femur. The FICB may be thought of as an anterior approach to the lumbar plexus where local anaesthetic is injected proximally beneath the fascia iliaca, with the aim of blocking the femoral nerve ,obturator nerve and lateral cutaneous nerve of thigh simultaneously. In addition to providing effective analgesia, peripheral nerve blocks are increasingly preferred especially in frail patient groups such as the geriatric population which femoral fractures are the most common, because of their advantages such as avoiding the complications of neuraxial anesthesia and the side effects of opioids. FICB can be applied with ultrasound-guided suprainguinal or infrainguinal approaches. Studies on the superiority of the two methods used in clinical practice are limited. In this study, it is aimed to compare the suprainguinal (Group S) and infrainguinal (Group I) approaches of FICB applied in the preoperative period in femoral fractures in which spinal anesthesia method was chosen. These two methods will be compared in terms of postoperative pain scores (11-point numeric scale), morphine consumption (by intravenous patient controlled analgesia for postoperative 24 hours) and possible side effects-complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2021
CompletedFirst Posted
Study publicly available on registry
December 29, 2021
CompletedStudy Start
First participant enrolled
February 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 27, 2022
CompletedDecember 1, 2022
November 1, 2022
3 months
October 16, 2021
November 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Morphine Consumption
postoperative morphine consumption will be recorded as milligrams for first 24 hours by intravenous patient controlled analgesia (PCA) (mg/24 hours)
24 hours
Secondary Outcomes (6)
Baseline Pain
0. hours
Positional Pain
0. hours
Postoperative 2nd Hour Pain
2. hours
Postoperative 8th Hour Pain
8. hours
Postoperative 16th Hour Pain
16. hours
- +1 more secondary outcomes
Study Arms (2)
Group S: Suprainguinal Performed FICB
ACTIVE COMPARATORSuprainguinal Performed FICB
Group I: Infrainguinal Performed FICB
ACTIVE COMPARATORInfrainguinal Performed FICB
Interventions
Linear ultrasound probe places above inguinal ligament sagittally, close to the femoral crease and superior-lateral to the femoral artery. It is aimed to spreading local anesthetics under the fascia iliaca medial-laterally
Linear ultrasound probe places below inguinal ligament transversally, close to the femoral crease and lateral to the femoral artery. It is aimed to spreading local anesthetics under the fascia iliaca medial-laterally
Eligibility Criteria
You may qualify if:
- Undergo femoral fracture surgery
- ASA 1-2-3
- years and older
- Accepting preoperative fascia iliaca compartment block application
You may not qualify if:
- Patients younger than 18 years
- Patients with an ASA score of 4 and greater than 4
- Patients who are unable to read, understand and sign the consent form
- Patients who do not want to sign the consent form
- Patients deemed unsuitable by the investigator
- Patients with body weight less than 50 kg
- Patients with hypersensitivity to local anesthetics
- Patients with known neuropsychiatric disease
- Patients with coagulopathic disease or anticoagulant drug use that interferes with the application of neuraxial anesthesia or peripheral nerve blockade
- Patients with infection or active skin lesion at the application site of neuraxial anesthesia or peripheral nerve blockade
- Patients who need to be switched to general anesthesia due to spinal anesthesia insufficiency or complications before the operation is completed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara City Hospital
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşe Lafçı
Ankara City Hospital Bilkent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
October 16, 2021
First Posted
December 29, 2021
Study Start
February 9, 2022
Primary Completion
April 30, 2022
Study Completion
November 27, 2022
Last Updated
December 1, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share